New hope for fighting back against aggressive brain cancer
Disease control
Not yet recruiting
This study is testing a new drug combination for adults whose glioblastoma brain cancer has come back after initial treatment. The goal is to see if the experimental drug STAR-001, given with the blood pressure medicine spironolactone, is safe and can help control the tumor. Rese…
Phase: PHASE1, PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC